Exxon Mobil: Analysts' Upgrades, Downgrades

Potash (POT) estimates, target boosted at Soleil to $100, according to Soleil Securities. Estimates also upped, as the company is realizing higher nutrient selling prices. Hold rating.

Patterson-UTI (PTEN) estimates upped at Morgan Stanley through 2012, Morgan Stanley said. Company is realizing higher dayrates. Overweight rating and $22 price target.

Standard Pacific (SPE) numbers lowered at UBS. Shares of SPF now seen reaching $4.50, according to UBS. Estimates also cut, given a weaker order outlook. Neutral rating.

Sunoco (SUN) estimates boosted at Morgan Stanley through 2011. Company is cutting costs and realized a higher capture rate. Overweight rating and $45 price target.

Teradyne (TER) estimates upped at UBS through 2011, UBS said. System-on-a-chip business is ramping. Buy rating and $13.50 price target.

Thoratec (THOR) estimates raised at UBS through 2011, according to UBS. Company boosted guidance. Buy rating and $51 price target.

Tesoro (TSO) price target lifted at Barclays a dollar to $14. Encouraged by managements restructuring efforts, Barclays said. Reiterate Equal Weight rating.

Varian Semiconductor (VSEA) estimates boosted at UBS through 2011, according to UBS. Company raise guidance and should continue to gain market share in its core business. Buy rating and $41 price target.

MEMC Electronic (WFR) numbers cut at UBS. Shares of WFR now seen reaching $13.50, according to UBS. Estimates also reduced, because of limited solar wafer supply. Buy rating.

Whiting Petroleum (WLL) price target higher at Barclays. WLL price target increased to $118 from $113. The Bakken Shale should underpin strong operations through 2010, Barclays said. Maintain Overweight rating.

Exxon Mobil (XOM) estimates raised at Barclays. XOM 2010 and 2011 EPS estimates increased to $5.60 and $6.50, respectively. Strong operating results in 2Q10, Barclays said. Maintain Overweight rating.

>To order reprints of this article, click here: Reprints